Mizuho MedyLtd Future Growth
Future criteria checks 0/6
Mizuho MedyLtd's revenue and earnings are forecast to decline at 0.4% and 6.5% per annum respectively. EPS is expected to decline by 10.9% per annum. Return on equity is forecast to be 15.3% in 3 years.
Key information
-6.5%
Earnings growth rate
-10.9%
EPS growth rate
| Medical Equipment earnings growth | 12.6% |
| Revenue growth rate | -0.4% |
| Future return on equity | 15.3% |
| Analyst coverage | Low |
| Last updated | 11 Nov 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 10,800 | 2,940 | 2,600 | N/A | 1 |
| 12/31/2025 | 10,300 | 2,800 | 2,500 | N/A | 1 |
| 12/31/2024 | 10,500 | 3,040 | 3,300 | N/A | 1 |
| 9/30/2024 | 10,988 | 3,497 | N/A | N/A | N/A |
| 6/30/2024 | 11,082 | 3,802 | 2,955 | 3,261 | N/A |
| 3/31/2024 | 11,340 | 3,998 | N/A | N/A | N/A |
| 12/31/2023 | 10,989 | 3,774 | 3,721 | 3,991 | N/A |
| 9/30/2023 | 12,290 | 4,533 | N/A | N/A | N/A |
| 6/30/2023 | 14,843 | 6,096 | 6,778 | 7,030 | N/A |
| 3/31/2023 | 15,784 | 6,667 | N/A | N/A | N/A |
| 12/31/2022 | 17,581 | 7,838 | 5,993 | 6,172 | N/A |
| 9/30/2022 | 15,842 | 6,867 | N/A | N/A | N/A |
| 6/30/2022 | 14,097 | 5,723 | 6,344 | 6,465 | N/A |
| 3/31/2022 | 14,882 | 6,082 | N/A | N/A | N/A |
| 12/31/2021 | 13,137 | 4,816 | 5,438 | 5,596 | N/A |
| 9/30/2021 | 12,290 | 4,559 | N/A | N/A | N/A |
| 6/30/2021 | 8,895 | 2,695 | 564 | 700 | N/A |
| 3/31/2021 | 5,596 | 960 | N/A | N/A | N/A |
| 12/31/2020 | 4,205 | 306 | 198 | 295 | N/A |
| 9/30/2020 | 4,789 | 286 | N/A | N/A | N/A |
| 6/30/2020 | 5,244 | 468 | 123 | 564 | N/A |
| 3/31/2020 | 5,663 | 600 | N/A | N/A | N/A |
| 12/31/2019 | 6,427 | 874 | -16 | 745 | N/A |
| 9/30/2019 | 6,282 | 816 | N/A | N/A | N/A |
| 6/30/2019 | 6,176 | 795 | -190 | 577 | N/A |
| 3/31/2019 | 6,089 | 787 | N/A | N/A | N/A |
| 12/31/2018 | 6,423 | 919 | -47 | 670 | N/A |
| 9/30/2018 | 6,329 | 937 | N/A | N/A | N/A |
| 6/30/2018 | 6,188 | 876 | N/A | 878 | N/A |
| 3/31/2018 | 6,143 | 856 | N/A | N/A | N/A |
| 12/31/2017 | 5,624 | 660 | N/A | 877 | N/A |
| 9/30/2017 | 5,585 | 598 | N/A | N/A | N/A |
| 6/30/2017 | 5,337 | 518 | N/A | 716 | N/A |
| 3/31/2017 | 5,128 | 475 | N/A | N/A | N/A |
| 12/31/2016 | 4,961 | 395 | N/A | 187 | N/A |
| 9/30/2016 | 4,409 | 255 | N/A | N/A | N/A |
| 12/31/2015 | 4,082 | 257 | N/A | 17 | N/A |
| 12/31/2014 | 3,986 | 317 | N/A | N/A | N/A |
| 12/31/2013 | 3,248 | 139 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4595's earnings are forecast to decline over the next 3 years (-6.5% per year).
Earnings vs Market: 4595's earnings are forecast to decline over the next 3 years (-6.5% per year).
High Growth Earnings: 4595's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 4595's revenue is expected to decline over the next 3 years (-0.4% per year).
High Growth Revenue: 4595's revenue is forecast to decline over the next 3 years (-0.4% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4595's Return on Equity is forecast to be low in 3 years time (15.3%).